Inicio › Trastorno depresivo mayor › Nueva York

Ensayos clínicos de Trastorno depresivo mayor en Nueva York

42 estudios sobre Trastorno depresivo mayor buscan participantes en Nueva York.

Ciudades en Nueva York

Texto oficial del estudio (inglés)

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Adams Clinical Harlem, New York
New York State Psychiatric Institute, New York
Adams Clinical Bronx, The Bronx

ReclutandoFase 3

Edades de 18 a 85 · Todos los sexos · Actualizado el 13 nov 2026 · NCT06793397

The Role of mGluR5 in CBT-I

Stony Brook University: Dept of Psychiatry, Stony Brook

ReclutandoFase 4

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT07076342

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

Seaport Investigator Site, Brooklyn
Seaport Investigator Site, Cedarhurst
Seaport Investigator Site, New York
y 1 más

ReclutandoFase 2

Edades de 18 a 65 · Todos los sexos · Actualizado el 10 nov 2026 · NCT07065240

Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder

Icahn School of Medicine at Mount Sinai, Center for Psychedelic Therapy Research, New York

ReclutandoFase 2

Edades de 21 a 80 · Todos los sexos · Actualizado el 6 nov 2026 · NCT06592833

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

Integrative Clinical Trials LLC, Brooklyn

ReclutandoFase 2

Edades de 18 a 65 · Todos los sexos · Actualizado el 5 nov 2026 · NCT07284667

Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression

Icahn School of Medicine at Mount Sinai, New York

ReclutandoFase 2

Edades de 18 a 90 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06559826

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

Adams Clinical Harlem, New York

ReclutandoFase 3

Edades de 18 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07412756

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Integrative Clinical Trials LLC, Brooklyn
SPRI Clinical Trials, LLC, Brooklyn
Bioscience Research LLC, Mount Kisco
y 1 más

ReclutandoFase 3

Edades de 18 a 74 · Todos los sexos · Actualizado el 3 nov 2026 · NCT06559306

A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

Adams Clinical Bronx, The Bronx

ReclutandoFase 3

Edades de 18 a 75 · Todos los sexos · Actualizado el 3 nov 2026 · NCT07775300

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

SPRI Clinical Trials, LLC, Brooklyn
Manhattan Behavioral Medicine, New York

ReclutandoFase 3

Edades de 18 a 65 · Todos los sexos · Actualizado el 3 nov 2026 · NCT05850689

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

Bioscience Research LLC, Mount Kisco
Fieve Clinical Research Inc, New York
Adams Clinical Harlem, New York
y 1 más

ReclutandoFase 3

Edades de 18 a 74 · Todos los sexos · Actualizado el 3 nov 2026 · NCT07573176

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Neurocrine Clinical Site, Cedarhurst
Neurocrine Clinical Site, Mount Kisco
Neurocrine Clinical Site, New York
y 2 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT06966401

Dupilumab in Major Depressive Disorder

The Dennis S. Charney, MD, Depression and Anxiety Discovery Center, New York

ReclutandoFase 2Se aceptan voluntarios sanos

Edades de 18 a 65 · Todos los sexos · Actualizado el 2 nov 2026 · NCT07908563

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

Clinical Research Site, New York

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 oct 2026 · NCT07621237

Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

SPRI Clinical Trials, Brooklyn
Manhattan Behavioral Medicine, New York

ReclutandoFase 2

Edades de 18 a 70 · Todos los sexos · Actualizado el 28 oct 2026 · NCT07226661

Study of ALTO-300 in MDD

Site 283, New York

ReclutandoFase 2

Edades de 18 a 70 · Todos los sexos · Actualizado el 26 oct 2026 · NCT05922878

A Study to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Neurocrine Clinical Site, Glen Oaks

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 oct 2026 · NCT07196501

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

Mount Sinai Hospital, New York

Reclutando

Edades de 22 a 70 · Todos los sexos · Actualizado el 16 oct 2026 · NCT06423430

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

Draig Clinical Site, New York
Draig Clinical Site, New York

ReclutandoFase 2

Edades de 18 a 75 · Todos los sexos · Actualizado el 14 oct 2026 · NCT07610473

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Clinical Research Site, Brooklyn
Clinical Research Site, New York
Clinical Research Site, New York
y 2 más

ReclutandoFase 3

Edades de 18 a 65 · Todos los sexos · Actualizado el 13 oct 2026 · NCT07484217

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Draig Clinical Site, New York

ReclutandoFase 2

Edades de 18 a 75 · Todos los sexos · Actualizado el 8 oct 2026 · NCT07300969

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

Vanda Investigational Site, New York
Vanda Investigational Site, New York
Vanda Investigational Site, Staten Island

ReclutandoFase 3

Edades de 18 a 65 · Todos los sexos · Actualizado el 24 sept 2026 · NCT06830044

DBS for TRD With the Medtronic Percept PC

Icahn School of Medicine at Mount Sinai, Mount Sinai West, New York

Reclutando

Edades de 25 a 70 · Todos los sexos · Actualizado el 22 sept 2026 · NCT05773755

Pattern Separation in Major Depressive Disorder

New York State Psychiatric Institute (NYSPI), New York

ReclutandoFase 1

Edades de 18 a 50 · Todos los sexos · Actualizado el 15 sept 2026 · NCT07139834

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Neurocrine Clinical Site, New York

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 11 ago 2026 · NCT06911112

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Neurocrine Clinical Site, Cedarhurst
Neurocrine Clinical Site, New York

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 ago 2026 · NCT06963021

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Neurobehavioral Research, Inc., Cedarhurst

ReclutandoFase 2

Edades de 18 a 64 · Todos los sexos · Actualizado el 3 ago 2026 · NCT06547489

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Neurobehavioral Research, Inc, Cedarhurst
IMA Clinical Research - NYC Midtown, New York
IMA Clinical Research - NYC Uptown, New York

ReclutandoFase 2

Edades de 18 a 64 · Todos los sexos · Actualizado el 27 jul 2026 · NCT07115329

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

Ima Clinical Research - Manhattan /ID# 278212, New York
Manhattan Behavioral Medicine /ID# 277910, New York

ReclutandoFase 2

Edades de 18 a 65 · Todos los sexos · Actualizado el 15 jun 2026 · NCT07276997

tDCS: Sleep to Mood in Depression (S2M-D)

NYU Langone Health, New York

Reclutando

Edades de 18 a 65 · Todos los sexos · Actualizado el 8 jun 2026 · NCT07572526

Triage Survey for Psychiatry Research Eligibility

Adams Clinical, Harlem, New York
Adams Clinical, Bronx, The Bronx

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 20 may 2026 · NCT05800925

Aβ Dynamics in LLMD

NYU Langone Health, New York
Nathan S. Kline Institute for Psychiatric Research, Orangeburg

ReclutandoFase 4

Edades de 60 en adelante · Todos los sexos · Actualizado el 6 may 2026 · NCT05004987

Mindfulness-Based fMRI Neurofeedback for Depression

Columbia University Irving Medical Center, New York

Reclutando

Edades de 13 a 18 · Todos los sexos · Actualizado el 29 abr 2026 · NCT05617495

Maintenance rTMS for Depression (Maitr-De)

Weill Cornell Medicine, New York

Reclutando

Edades de 18 a 80 · Todos los sexos · Actualizado el 29 abr 2026 · NCT06938841

Neutralizing Interleukin (IL)-6

Icahn School of Medicine at Mount Sinai, New York

ReclutandoFase 2Se aceptan voluntarios sanos

Edades de 18 a 70 · Todos los sexos · Actualizado el 29 abr 2026 · NCT07493317

Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality

Weill Cornell Medicine, New York

Reclutando

Edades de 50 a 80 · Todos los sexos · Actualizado el 27 mar 2026 · NCT05925322

Biomarker-guided rTMS for Treatment Resistant Depression

Weill Cornell Medicine, New York

ReclutandoFase 3

Edades de 22 a 65 · Todos los sexos · Actualizado el 25 feb 2026 · NCT04041479

Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33

NYU Langone Health, New York
Nathan Kline Institute for Psychiatric Research, Orangeburg

Reclutando

Edades de 18 a 65 · Todos los sexos · Actualizado el 5 feb 2026 · NCT05573074

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

Autobahn Site #105, Brooklyn
Autobahn Site #134, Brooklyn
Autobahn Site #104, Staten Island

ReclutandoFase 2

Edades de 18 a 65 · Todos los sexos · Actualizado el 20 ene 2026 · NCT06633016

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Neurocrine Clinical Site, Mount Kisco

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 oct 2025 · NCT06786624

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.